Trial of Ixazomib, Dexamethasone and Rituximab in Patients With Untreated Waldenstrom's Macroglobulinemia
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Dexamethasone
Related studies linked through entity extraction aliases.
Study of ACY-241 Alone and in Combination With Pomalidomide and Dexamethasone in Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Selinexor (KPT- 330), Lenalidomide, & Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Lenalidomide With or Without Ixazomib Citrate and Dexamethasone in Treating Patients With Residual Multiple Myeloma After Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Prevention of POV After Paediatric Tonsillectomy
- Status
- COMPLETED
- Phase
- PHASE4
Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Vitrectomy Under Local Anesthesia
- Status
- UNKNOWN
- Phase
- PHASE4
Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis
- Status
- COMPLETED
- Phase
- PHASE2
Dexamethasone in Preventing Hearing Loss in Patients Receiving Cisplatin
- Status
- WITHDRAWN
- Phase
- NA
Study of Bortezomib,Lenalidomide,Dexamethasone & Elotuzumab in Newly Diagnosed MM
- Status
- COMPLETED
- Phase
- PHASE2
Analgesic Effects Of Dexamethasone; Its Use To Reduce Post Operative Pain Scores
- Status
- COMPLETED
- Phase
- PHASE2
Role of Dexamethasone in the Conservative Treatment of Chronic Subdural Hematoma
- Status
- TERMINATED
- Phase
- PHASE4
CyBorD vs. PAD in the Treatment of Newly Diagnosed Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE3
Dexamethasone Versus Local Infiltration Technique for Tonsillectomy in Children
- Status
- COMPLETED
- Phase
- NA
Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Bortezomib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE2
A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Caffeic Acid Tablets as a Second-line Therapy for ITP
- Status
- COMPLETED
- Phase
- PHASE3
Open-label Extended Access Program on Lenalidomide Plus Dexamethasone in Chinese Subjects With Relapsed/Refractory Multiple Myeloma Who Participated in CC-5013-MM021 for at Least 1 Year
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2